Table 1 Summary of patient characteristics

Age

18 (<1–65)*

Children ( <18 y )

29

Sex ( M/F )

38/23

Diagnosis:

Non-malignant

13

Acute myeloid leukemia/Acute lymphoid leukemia

12/13

Chronic lymphoid leukemia

4

Myelodysplastic syndrome

11

Other malignancies

8

Stage ( early/late )

16/32

Donor age

26 (0–62)

Donor sex ( M/F )

38/23

Donor

Sibling/HLA-identical, related

21

MUD

32

HLA-mismatched, unrelated

8

Conditioning

MAC/RIC

34/27

Chemo-based

38

TBI-based

23

ATG

47 (77%)

GVHD prophylaxis

CsA ± MTX

41

CsA + Prednisolon

3

Tacrolimus + Sirolimus

16

CsA + MTX + Cy

1

Stem cell source:

BM/PBSCs/CB

25/31/5